{"url_path":"/sec/mrvi/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1823239/0001823239-26-000024-index.html","accession_number":"0001823239-26-000024","cik":"0001823239","ticker":"MRVI","issuer_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1823239/0001823239-26-000024-index.html","primary_entity_key":"0001823239","primary_entity_name":"MARAVAI LIFESCIENCES HOLDINGS, INC."},"word_count":474,"has_tables":true,"body_markdown":"Item 6.    Exhibits\n\nExhibit NumberDescription\n\n3.1\n[Amended and Restated Certificate of Incorporation of Maravai LifeSciences Holdings, Inc. dated November 19, 2020 (incorporated by reference to Exhibit 3.1 to Maravai Life Sciences Holdings, Inc.’s Form 8-K filed on November 25, 2020)](https://www.sec.gov/Archives/edgar/data/1823239/000119312520303088/d31788dex31.htm)\n\n3.2\n[Amended and Restated Bylaws of Maravai LifeSciences Holdings, Inc. dated November 19, 2020 (incorporated by reference to Exhibit 3.2 to Maravai Life Sciences Holdings, Inc.’s Form 8-K filed on November 25, 2020).](https://www.sec.gov/Archives/edgar/data/1823239/000119312520303088/d31788dex32.htm)\n\n10.1§\n\n[Amended and Restated Employment Agreement of](ex101-kurtoreshackxaremplo.htm)[Kurt Oreshack](ex101-kurtoreshackxaremplo.htm)[, dated as of May 8, 2023 among Maravai LifeSciences Holdings, Inc.,](ex101-kurtoreshackxaremplo.htm)[M](ex101-kurtoreshackxaremplo.htm)[aravai Intermediate Holdings](ex101-kurtoreshackxaremplo.htm)[, LLC](ex101-kurtoreshackxaremplo.htm)[and](ex101-kurtoreshackxaremplo.htm)[Kurt Oreshack](ex101-kurtoreshackxaremplo.htm)[.](ex101-kurtoreshackxaremplo.htm)\n\n10.2\n\n[Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Annual Director Grant), filed herewith.](ex102-mrvirsuagmt2023rsubod.htm)\n\n10.3\n\n[Amendment No. 1 to Employment Agreement, effective as of February 19, 2026, by and among Maravai LifeSciences Holdings, Inc., Maravai Intermediate Holdings, LLC and Bernd Brust (incorporated by reference to Exhibit 10.42 to Maravai Life Sciences Holdings, Inc.’s Form 10-K filed on February 26, 2026)](https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/exhibit1042-mrvixamendment.htm).\n\n31.1\n[Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.](mrvi-q12026form10xqxex311x.htm)\n\n31.2\n[Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.](mrvi-q12026form10xqxex312x.htm)\n\n32.1*\n[Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350.](mrvi-q12026xform10xqxex321.htm)\n\n32.2*\n[Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350.](mrvi-q12026xform10xqxex322.htm)\n\n101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.\n\n101.SCHXBRL Taxonomy Extension Schema Document.\n\n101.CALXBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEFXBRL Extension Definition Linkbase Document.\n\n101.LABXBRL Taxonomy Label Linkbase Document.\n\n101.PREXBRL Taxonomy Extension Presentation Linkbase Document.\n\n104Cover Page Interactive Data File (formatted as Inline XBRL and contained in exhibit 101)\n\n_______________\n\n*\nThe certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference in such filing.\n\n§\nExhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided on a supplemental basis to the SEC upon request.\n\n38\n\n[Table of Contents](#ied43387d9d824ef292825d07e284e584_7)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\nMaravai LifeSciences Holdings, Inc.\n\nBy:\n/s/ Rajesh Asarpota\n\nName:\nRajesh Asarpota\n\nTitle:Chief Financial Officer\n\nDate: May 8, 2026\n\n39"}